Separates components and records UV absorbance. A peak-area percentage describes included detector response under that method; it is not automatically identity, weight-percent assay, or total impurity coverage.
Analytical testing literacy
Peptide analytical testing, explained.
HPLC-UV, LC-MS, LC-MS/MS, ICP-MS, quantitative assay, sterility, and bacterial-endotoxin testing answer different questions. Learn what each result can support—and what remains untested.
Start with the question
No single test creates a complete quality conclusion.
A report is interpretable only when the sample, method, result, units, calculation basis, and limitations are clear. Identity, chromatographic purity, quantity, elemental impurities, sterility, and bacterial endotoxin are separate analytical questions. One result should never be used as a substitute for an unreported test.
Method map
Six scopes that should not be collapsed into one score.
LC-MS adds mass-to-charge evidence for detected ions after liquid-chromatographic separation. LC-MS/MS isolates selected precursor ions and examines product ions or transitions, which can add selectivity or structural evidence. Neither label alone proves total purity or vial quantity.
Measures specified elements at trace concentrations when supported by suitable preparation, calibration, controls, units, and limits. It does not establish peptide identity, organic purity, sterility, or bacterial endotoxin.
A calibrated quantitative procedure can estimate analyte amount or concentration relative to a suitable reference. It answers a different question from normalized chromatographic peak-area purity.
A dedicated microbiological method asks whether viable contaminating microorganisms were detected under the specified test conditions. The conclusion applies to the tested sample and does not establish bacterial-endotoxin control.
A dedicated, product-suitable method reports endotoxin against a stated result or limit. Endotoxin testing does not establish sterility, peptide identity, chromatographic purity, or vial quantity.
Report reading
Apply the same six checks to every method.
- Sample and provenance
- Identify the submitted material, lot or batch, who selected it, how it was handled, and whether chain of custody is independently supported.
- Laboratory and method
- Verify the issuing laboratory independently, name the procedure actually used, and check whether any claimed accreditation covers that specific analytical scope.
- Result, units, and basis
- Read the reported value with its units and calculation basis. Area percent, mass per vial, concentration, percent assay, and elemental concentration are not interchangeable.
- Specification and limits
- Separate the measured result, reporting or quantitation limit, and formal acceptance criterion. Not every independent report includes a release specification.
- Supporting data
- Review the relevant chromatograms, spectra, integrations, calibration or reference-standard information, controls, replicate results, uncertainty, and analyst notes.
- Boundaries
- Record what was not tested, what cannot be inferred, whether the sample represents current inventory, and which follow-up evidence would be needed.
Interpretation boundaries
Four shortcuts that weaken a testing claim.
Different compounds can ionize and produce detector responses differently. An LC-MS or LC-MS/MS signal percentage is not automatically total sample purity.
A sterility result does not substitute for bacterial-endotoxin testing, and an endotoxin result does not establish absence of viable microorganisms.
A laboratory may be accredited while a particular peptide method falls outside its accredited scope. Check the current certificate and scope together.
A valid result applies to the submitted sample. Representativeness depends on sampling, batch linkage, chain of custody, and consistency over time.
Analytical testing FAQ
Keep every conclusion tied to the method.
01What is the difference between LC-MS and LC-MS/MS?
LC-MS combines liquid-chromatographic separation with mass measurement of detected ions. LC-MS/MS adds a second mass-analysis stage: selected precursor ions are fragmented or monitored through product-ion transitions. This can add selectivity or structural evidence, but the exact conclusion still depends on the method, controls, reference material, and acceptance criteria.
02Does LC-MS determine peptide purity?
Not automatically. LC-MS can reveal detected components and provide mass-based evidence, but compounds can separate, ionize, and respond differently. A detector-response percentage is not inherently weight-percent purity, total impurity coverage, or quantitative content.
03Does ICP-MS prove a sample is heavy-metal free?
No absolute “free” conclusion follows from the instrument name. The report should identify each element measured, preparation and method, result, units, sample basis, reporting or quantitation limit, and any applicable acceptance criterion.
04Can one test establish both sterility and endotoxin control?
No. Sterility and bacterial-endotoxin testing use different analytical questions and methods. Neither should be inferred from HPLC, mass spectrometry, ICP-MS, assay, or the other microbiological result.
05Does ISO/IEC 17025 accreditation cover every test a laboratory sells?
No. Accreditation is assessed against a defined scope. Review the current certificate and scope to determine whether the specific method or field of testing is covered rather than relying on an organization-level accreditation claim.
Standards and guidance
Use each framework for the question it addresses.
- FDA and ICH Q2(R2) and Q14
- Official final pharmaceutical guidance addresses analytical-procedure validation and development.
- ISO/IEC 17025
- The laboratory standard addresses competence, impartiality, and consistent operation within an assessed scope.
- Eurachem
- General guidance addresses fitness for purpose, validation, verification, sampling, and performance characteristics.
- Compendial and method-specific requirements
- Sterility, endotoxin, elemental-impurity, identity, purity, and assay procedures may have additional requirements tied to the sample, intended use, specification, and jurisdiction. These sources are complementary, not interchangeable.
Official pharmaceutical guidance
Analytical procedures require development and validation.
Canadian implementation
Health Canada publishes implemented ICH quality guidelines.
Laboratory competence
Confirm the current accredited scope.
Method-specific guidance